Journal of Clinical Immunology

, Volume 28, Supplement 1, pp 56–61 | Cite as

Autoimmunity in IgA Deficiency: Revisiting the Role of IgA as a Silent Housekeeper

  • Cristina M. A. JacobEmail author
  • Antonio C. Pastorino
  • Kristine Fahl
  • Magda Carneiro-Sampaio
  • Renato C. MonteiroEmail author


Both systemic and organ-specific autoimmune diseases are major manifestations of IgA deficiency (IgAD), the most common primary immunodeficiency. In addition, to discuss the clinical findings of IgAD patients, we proposed a hypothesis to explain the high association with autoimmune phenomena. Based on observations, interactions of monomeric IgA with FcαRI result in a partial phosphorylation of FcRγ-associated FcαRI, notably in the immunoreceptor tyrosine-based activation motif (ITAM) inducing the recruitment of the SHP-1 tyrosine phosphatase. This leads to deactivation of several activating pathways of the immune system including immunoreceptors that bear ITAM motif and ITAM-independent receptors. Consequently, inflammatory reactions and auto-immune process would be prevented.


IgA deficiency autoimmunity clinical evolution Fc receptor physiopathology 



This work is supported by Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP-grant 2002/05880-4.


  1. 1.
    Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol. 2006;208:270–82.PubMedCrossRefGoogle Scholar
  2. 2.
    Corthesy B. Roundtrip ticket for secretory IgA: role in mucosal homeostasis? J Immunol. 2007;178:27–32.PubMedGoogle Scholar
  3. 3.
    Russell MW, Sibley DA, Nikolova EB, Tomana M, Mestecky J. IgA antibody as a non-inflammatory regulator of immunity. Biochem Soc Trans. 1997;25:466–70.PubMedGoogle Scholar
  4. 4.
    Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Conley ME, Notarangelo LD, Etzioni A. Representing PAGID and ESID. Diagnostic criteria for primary immunodeficiencies. Clinical Immunol. 1999;93(3):190–7.CrossRefGoogle Scholar
  6. 6.
    Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497–502.PubMedCrossRefGoogle Scholar
  7. 7.
    Carneiro-Sampaio MMS, Carbonare SB, Rozentraub RB, de Araújo MN, Riberiro MA, Porto MH. Frequency of selective IgA deficiency among Brazilian blood donors and healthy pregnant women. Allergol et Immunopathol. 1989;17(4):213–6.Google Scholar
  8. 8.
    Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27(1):101–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Weber-Mzell D, Kotanko P, Hauer AC, Goriup U, Haas J, Lanner N, et al. Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians. Eur J Clin Invest. 2004;34(3):224–8, Mar.PubMedCrossRefGoogle Scholar
  10. 10.
    Ozkan H, Atlihan G, Genel F, Targan S, Gunvar T. IgA and/or subclass deficiency in children with recurrent respiratory infections and its relationship with chronic pulmonary damage. J Investig Allergol Clin Immunol. 2005;15:69–74.PubMedGoogle Scholar
  11. 11.
    Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood 2002;99(8):2694–702.PubMedCrossRefGoogle Scholar
  12. 12.
    Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev. 2002;16:61–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Carneiro-Sampaio MMS, Coutinho A. Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies. Adv Immunol. 2007;95:51–82.PubMedCrossRefGoogle Scholar
  14. 14.
    Etzioni A. Immune deficiency and autoimmunity. Autoimmun Rev. 2003;2:364–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Sinclair D, Saas M, Turk A, Goble M, Kerr D. Do we need to measure total serum IgA to exclude IgA deficiency in coeliac disease? J Clin Pathol. 2006;59:736–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Cataldo F, Marino V, Ventura A, Bottaro G, Corazza GR. Prevalence and clinical features of selective immunoglobulin A deficiency in celiac disease: an Italian multicentre study. Gut 1998;42:362–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Badcock LJ, Clarke S, Jones PW, Dawes PT, Mattey DL. Abnormal IgA levels in patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62:83–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Cassidy JT, Kitson RK, Seiby CL. Selective IgA deficiency in children and adults with systemic lupus erythematosus. Lupus 2007;16:647–50.PubMedCrossRefGoogle Scholar
  19. 19.
    Koskinen S. Long-term follow-up of health in blood donors with primary selective IgA deficiency. J Clin Immunol. 1996;16(3):165–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Gerbase-Delima M, Pinto LC, Grumach A, Carneiro-Sampaio MM. HLA antigens and haplotypes in IgA-deficient Brazilian paediatric patients. Eur J Immunogenet. 1988;25:281–5.CrossRefGoogle Scholar
  21. 21.
    Pan-Hammarstrom Q, Salzer U, Du L, Bjorkander J, Cunningham-Rundles C, Nelson DL, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet. 2007;39:429–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Castigli E, Wilson S, Garibyan L, Rachid R, Bonilla F, Schneider L, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet. 2007;39:430–1.PubMedCrossRefGoogle Scholar
  23. 23.
    Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol. 2001;21:303–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Pasquier B, Launay P, Kanamaru Y, Moura IC, Pfirsch S, Ruffie C, et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005;22:31–42.PubMedGoogle Scholar
  25. 25.
    Monteiro RC, Van De Winkel JG. IgA Fc receptors. Annu Rev Immunol. 2003;21:177–204.PubMedCrossRefGoogle Scholar
  26. 26.
    van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG. IgA and the IgA Fc receptor. Trends Immunol. 2001;22:205–11.PubMedCrossRefGoogle Scholar
  27. 27.
    Kanamaru Y, Pfirsch S, Vrtovsnik F, Loirat C, Deschenes G, Guérin-Marchand C, et al. Inhibitory ITAM signaling by FcαRI-γ controls multiple activating responses and prevents renal inflammation1. J Immunol 2008 (in press).Google Scholar
  28. 28.
    Chevailler A, Monteiro RC, Kubagawa H, Cooper MD. Immunofluorescence analysis of IgA binding by human mononuclear cells in blood and lymphoid tissue. J Immunol. 1989;142:2244–9.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Cristina M. A. Jacob
    • 1
    Email author
  • Antonio C. Pastorino
    • 1
  • Kristine Fahl
    • 1
  • Magda Carneiro-Sampaio
    • 1
  • Renato C. Monteiro
    • 2
    • 3
    Email author
  1. 1.Instituto da Criança, Hospital das Clinicas da Faculdade de MedicinaUniversidade de São PauloSão PauloBrasil
  2. 2.Institut National de la Santé et de la Recherche Médicale U699ParisFrance
  3. 3.Université Paris 7, Faculté de Médicine Denis Diderot, Hôpital BichatParisFrance

Personalised recommendations